AGENUS INC

AGEN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $42.9M $22.6M $24.8M $7.0M $3.0M $16.0M $2.8M $3.4M
Cost of Revenue $0 $536.1K $672.0K $0 $122.9K
Gross Profit $7.0M $2.5M $15.3M $2.8M $3.2M
Gross Margin 100.0% 82.4% 95.8% 100.0% 96.3%
Operating Expenses
Research & Development $116.1M $95.0M $70.4M $22.3M $13.0M $10.6M $11.0M $12.9M
SG&A Expense $33.7M $33.1M $28.4M $21.2M $14.5M $11.5M $10.8M $12.1M
Operating Income $-103.8M $-107.5M $-80.7M $-43.3M $-25.0M $-6.7M $-19.1M $-21.8M
Operating Margin -242.1% -476.1% -325.2% -620.9% -820.3% -42.2% -692.6% -647.5%
Interest Expense $31.3M $19.4M $4.3M $1.3M $2.4M $4.7M $4.2M $4.9M
Pretax Income $-120.7M $-127.0M $-93.3M $-42.5M $-30.1M
Income Tax Expense $0 $0 $-5.4M $0 $0 $0 $0
Net Income $-120.7M $-127.0M $-87.9M $-42.5M $-30.1M $-11.3M $-23.3M $-21.9M
Net Margin -281.5% -562.6% -354.1% -608.9% -987.5% -71.0% -844.6% -652.0%
EPS (Basic) $-0.02 $-0.02 $-0.02 $-0.01 $-0.02 $-0.01 $-0.02 $-0.02
EPS (Diluted) $-0.02 $-0.02 $-0.02 $-0.01 $-0.02 $-0.01 $-0.02 $-0.02
Shares Outstanding (Basic) 6.10B 5.36B 4.39B 3.85B 1.57B 1.39B
Shares Outstanding (Diluted) 6.10B 5.36B 4.39B 3.85B 1.57B 1.39B
Dividends Per Share
← Newer Page 2 of 3 Older →